Referred patients gain a specialized team dedicated to improving their daily lives:  

• Increased survival: heart failure clinics increase survival by up to 30% (American College of Cardiology); specialist-managed patients have a significantly lower risk of death.
• Fewer readmissions: heart failure clinics cut readmissions by 25-70%.
• Enhanced quality of life: multidisciplinary care, education, and support. 
• Personalized treatment plans: tailored to each patient’s diagnosis and lifestyle goals. 
• Direct access to advanced therapies: heart transplant, mechanical circulatory support, palliative care, and the latest clinical trials. 

You manage heart failure every day.  When cases grow complex, we act as an extension of your team - placing advanced, life-extending devices at Stage C while you continue long-term care. 

• Reclaim your time:  Advanced heart failure visits can run 45 minutes.  We handle them so you can see more patients - with appointments available now for your most critical cases.  
• All options in one place:  The full spectrum of advanced devices and therapies under one roof.  
• Intervene at pivotal moments:  Specialized training to act when advanced therapies make the biggest impact

A true partnership: when you refer, you remain central to your patient’s care team.  

• Seamless communication:  You’re informed at every step, with open dialogue between our teams.  
• Fast access: Patients are seen within 7-10 days of requesting an appointment.  
• Expanded team care:  Like structural heart and EP specialists, we join as a contributing expert - you remain the lead.  
• Patient education:  Resources that help patients understand their condition and options.

Stage C patients with any of the following may benefit from an advanced heart failure specialist:

• >= ED visits or hospitalizations for worsening HF in 12 months
• Persistent NYHA functional III-IV congestion or profound fatigue
• New atrial fibrillation, ventricular arrhythmias, or repetitive ICD shocks
• SBP < 90 mmHg or symptomatic hypotension
• Intolerance of optimally dosed beta-blockers, ARNI/ACE inhibitors/ARBs or MRA
• Clinical deterioration - worsening edema or symptoms, rising biomarkers, worse exercise testing, decompensated hemodynamic status, or progressive remodeling on imaging
• LVEF <= 35% despite >=3 months of GDMT